Skip to main content

Paul Meister, John Sharp, Samuel Mitchell

Paul Meister said this week that he will not stand for reelection as chairman of the board of Thermo Fisher Scientific at the firm’s annual meeting on May 15. In anticipation of his retirement, Meister has already relinquished his position as chairman. The firm did not say whether any of the other directors have assumed his duties.
 
Thermo Fisher said it expects to identify a new director prior to its upcoming meeting.
 

 
John Sharp, vice president of finance for Sequenom, notified the firm that he would leave the firm on April 17, according to a regulatory filing last week.
 

 
Samuel Mitchell, a senior scientist at an agriculture and biotechnology facility in Belfast, Northern Ireland, has won an HPLC system and a TOF LC mass spectrometer through an Agilent Technologies European sweepstakes, Agilent said this week.
 
Mitchell, of the Agri-Food & Biosciences Institute, won a 1200 Series liquid chromatography system and a 6510 Quadrupole Time-of-Flight LC/mass spectrometer, Agilent said. The company valued Mitchell’s winnings at $525,000. 
 
Mitchell said the new technology “will enhance [the institute’s] technical capabilities thus helping us with future funding applications.”

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.